title: [Sharing uncertainties of prostate cancer screening].
abstract: The decision of whether our patients should undergo prostate cancer screening with the prostate specifc antigen (PSA) test remains daunting. The role of the primary care doctor is to help men decide between a potential decrease in mortality from a slow evolving but sometimes lethal cancer, and the risk of diagnosing and treating cancers that would have otherwise been indolent and asymptomatic. We can structure our discussions with three steps: choice, option, and decision making. A decision aid, such as the one that we have adapted and simplifed from the Collège des médecins du Québec, can help with this complex decision.
authors.forename: Kevin
authors.initials: K
authors.lastname: Selby
authors.forename: Reto
authors.initials: R
authors.lastname: Auer
authors.forename: Massimo
authors.initials: M
authors.lastname: Valerio
authors.forename: Patrice
authors.initials: P
authors.lastname: Jichlinski
authors.forename: Jacques
authors.initials: J
authors.lastname: Cornuz
mesh_terms: D003657:Decision Making; D003661:Decision Support Techniques; D006801:Humans; D008297:Male; D008403:Mass Screening; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000097:blood / Q000517:prevention & control*
chemical_list: D017430:Prostate-Specific Antigen